Literature DB >> 11840543

Two-dimensional mapping of three phenotype-associated isoforms of the prion protein in sporadic Creutzfeldt-Jakob disease.

Gianluigi Zanusso1, Pier Giorgio Righetti, Sergio Ferrari, Liliana Terrin, Alessia Farinazzo, Franco Cardone, Maurizio Pocchiari, Nicola Rizzuto, Salvatore Monaco.   

Abstract

Transmissible spongiform encephalopathies (TSE), or prion diseases, are mammalian neurodegenerative disorders characterized by a conformational modification of the host-encoded prion protein (PrP(C)) into an isoform which is detergent-insoluble and partially resistant to protease treatment (PrP(Sc)). Distinct types of PrP(Sc), differing in conformation and variation in the relative amount of their glycoforms, have been associated with different phenotypes of TSE. In sporadic Creutzfeldt-Jakob disease (sCJD), two major types of PrP(Sc), with proteinase K (PK)-resistant fragments of 21 and 19 kDa, have been described. No consensus exists, however, on the molecular classification of PrP(Sc) in sCJD, since further heterogeneity within PrPSc conformers has been reported. We studied 19 subjects with dementia or dementia/ataxia at onset and 12 subjects with ataxia at onset. Following two-dimensional gel electrophoresis, we characterized PrP(C) and PrP(Sc) species in normal and sCJD brains by immunoblotting with antibodies recognizing N-terminal and C-terminal PrP regions. Three types of PrP(Sc) were detected in detergent-insoluble fractions from sCJD brains, mainly consisting of full-length PrP(Sc) in subjects with rapidly progressive dementia, and two different sets of amino-truncated PrP(Sc) glycoforms in subjects with dementia/ataxia and ataxia at onset. Examination of the PrP(Sc) core fragment, following PK treatment and deglycosylation, confirmed the existence of three distinctive patterns. These findings have immediate implications for the molecular classification of sCJD.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11840543     DOI: 10.1002/1522-2683(200202)23:2<347::AID-ELPS347>3.0.CO;2-1

Source DB:  PubMed          Journal:  Electrophoresis        ISSN: 0173-0835            Impact factor:   3.535


  8 in total

1.  Proteolytic processing and glycosylation influence formation of porcine prion protein complexes.

Authors:  Krzysztof Nieznanski; Marcin Rutkowski; Magdalena Dominik; Dariusz Stepkowski
Journal:  Biochem J       Date:  2005-04-01       Impact factor: 3.857

2.  Mass spectrometric detection of attomole amounts of the prion protein by nanoLC/MS/MS.

Authors:  Bruce Onisko; Irina Dynin; Jesús R Requena; Christopher J Silva; Melissa Erickson; John Mark Carter
Journal:  J Am Soc Mass Spectrom       Date:  2007-03-28       Impact factor: 3.109

3.  Gerstmann-Sträussler-Scheinker disease and "anchorless prion protein" mice share prion conformational properties diverging from sporadic Creutzfeldt-Jakob disease.

Authors:  Gianluigi Zanusso; Michele Fiorini; Sergio Ferrari; Kimberly Meade-White; Ilaria Barbieri; Emiliana Brocchi; Bernardino Ghetti; Salvatore Monaco
Journal:  J Biol Chem       Date:  2014-01-07       Impact factor: 5.157

4.  Absolute quantification of prion protein (90-231) using stable isotope-labeled chymotryptic peptide standards in a LC-MRM AQUA workflow.

Authors:  Robert Sturm; Gloria Sheynkman; Clarissa Booth; Lloyd M Smith; Joel A Pedersen; Lingjun Li
Journal:  J Am Soc Mass Spectrom       Date:  2012-06-20       Impact factor: 3.109

5.  Endogenous proteolytic cleavage of disease-associated prion protein to produce C2 fragments is strongly cell- and tissue-dependent.

Authors:  Michel Dron; Mohammed Moudjou; Jérôme Chapuis; Muhammad Khalid Farooq Salamat; Julie Bernard; Sabrina Cronier; Christelle Langevin; Hubert Laude
Journal:  J Biol Chem       Date:  2010-02-12       Impact factor: 5.157

6.  Ultra-high-pressure inactivation of prion infectivity in processed meat: a practical method to prevent human infection.

Authors:  Paul Brown; Richard Meyer; Franco Cardone; Maurizio Pocchiari
Journal:  Proc Natl Acad Sci U S A       Date:  2003-05-05       Impact factor: 11.205

7.  The polybasic N-terminal region of the prion protein controls the physical properties of both the cellular and fibrillar forms of PrP.

Authors:  Valeriy G Ostapchenko; Natallia Makarava; Regina Savtchenko; Ilia V Baskakov
Journal:  J Mol Biol       Date:  2008-09-04       Impact factor: 5.469

Review 8.  The role of prion strain diversity in the development of successful therapeutic treatments.

Authors:  Sara A M Holec; Alyssa J Block; Jason C Bartz
Journal:  Prog Mol Biol Transl Sci       Date:  2020-08-28       Impact factor: 3.622

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.